Kolinpharma S.p.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 15.31 million compared to EUR 12.48 million a year ago. Revenue was EUR 15.65 million compared to EUR 13.35 million a year ago.

Net income was EUR 0.342342 million compared to EUR 0.636968 million a year ago.